Format

Send to

Choose Destination
See comment in PubMed Commons below
J Cataract Refract Surg. 2012 Jul;38(7):1140-6. doi: 10.1016/j.jcrs.2012.01.031.

Incidence of glistenings with the latest generation of yellow-tinted hydrophobic acrylic intraocular lenses.

Author information

1
Service d'Ophtalmologie, CHU Pellegrin, Bordeaux, France.

Abstract

PURPOSE:

To evaluate the incidence of glistenings in a large series of consecutive eyes with a blue light-filtering hydrophobic acrylic intraocular lens (IOL) and the relationship with parameters such as age, sex, follow-up length, and corrected distance visual acuity (CDVA).

SETTING:

Service d'Ophtalmologie, Centre Hospitalier et Universitaire Bordeaux, Bordeaux, France.

DESIGN:

Cross-sectional study.

METHODS:

This study included 111 eyes of 74 patients (age range 33 to 86 years). All cases had cataract surgery with Acrysof SN60WF monofocal IOL implantation and had a routine postoperative examination between March 2011 and June 2011. The incidence and severity of glistenings were evaluated with the slitlamp. Also evaluated was their relationship with age, sex, follow-up length, IOL power, and CDVA. Glistenings were subjectively graded (0 = absent; 1 = moderate; 2 = dense).

RESULTS:

Glistenings occurred in 96 eyes (86.5%). Glistenings were of grade 1 severity in 45 eyes (40.5%) and of grade 2 severity in 51 eyes (45.9%). The follow-up was significantly longer in eyes with grade 2 glistenings (P ≤ .01). A limited, but significant, correlation was found between glistening severity and length of follow-up (r = 0.32, P<.01). Although there was a trend toward decreased visual acuities at higher glistening grades (r = 0.22, P = .01), there were no significant differences in CDVA between the glistening severity groups (P = .14).

CONCLUSIONS:

Glistenings were common in eyes with the blue light-filtering hydrophobic acrylic IOL and increased over time.

FINANCIAL DISCLOSURE:

No author has a financial or proprietary interest in any material or method mentioned.

Comment in

PMID:
22727284
DOI:
10.1016/j.jcrs.2012.01.031
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center